{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:09:12Z","timestamp":1759972152478,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.braindev.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T21:34:46Z","timestamp":1615671286000},"page":"729-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-GM2 antibody positive Guillain-Barr\u00e9 syndrome presenting with ataxia in a pediatric patient: An atypical manifestation"],"prefix":"10.1016","volume":"43","author":[{"given":"Elif","family":"Deliceo G\u00f6b\u00fct","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6nder","family":"Us","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U\u011fur","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10045","key":"10.1016\/j.braindev.2021.02.003_b0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2021.02.003_b0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Classification Group; GBS Classification Group. Guillain-Barr\u00e9 and Miller Fisher syndromes\u2014new diagnostic classification","volume":"10","author":"Wakerley","year":"2014","journal-title":"Nat Rev Neurol."},{"issue":"9","key":"10.1016\/j.braindev.2021.02.003_b0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.it.2013.05.001","article-title":"Glycolipid antigens and autoantibodies in autoimmune neuropathies","volume":"34","author":"Willison","year":"2013","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.braindev.2021.02.003_b0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3928\/00904481-20140325-13","article-title":"Approach to acute ataxia in childhood: diagnosis and evaluation","volume":"43","author":"Sivaswamy","year":"2014","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.braindev.2021.02.003_b0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp.2010.222836","article-title":"Ataxic Guillain-Barr\u00e9 syndrome and acute sensory ataxic neuropathy form a continuous spectrum","volume":"82","author":"Ito","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.braindev.2021.02.003_b0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","article-title":"Infectious origins of, and molecular mimicry in, Guillain-Barr\u00e9 and Fisher syndromes","volume":"1","author":"Yuki","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.braindev.2021.02.003_b0035","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/WCO.0000000000000361","article-title":"Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies","volume":"29","author":"Goodfellow","year":"2016","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.braindev.2021.02.003_b0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3988\/jcn.2018.14.3.401","article-title":"Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome","volume":"14","author":"Kim","year":"2018","journal-title":"J Clin Neurol"},{"issue":"04","key":"10.1016\/j.braindev.2021.02.003_b0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-0039-1688721","article-title":"Subacute-Onset Afferent Ataxia in Childhood: A Case Report","volume":"18","author":"Cecchin","year":"2020","journal-title":"J Pediatr Neurol"},{"issue":"1-2","key":"10.1016\/j.braindev.2021.02.003_b0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0165-5728(00)00461-6","article-title":"Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies","volume":"114","author":"Cavanna","year":"2001","journal-title":"J Neuroimmunol"},{"issue":"1-2","key":"10.1016\/j.braindev.2021.02.003_b0055","first-page":"226-31","article-title":"Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies","volume":"114","author":"O\u2019Hanlon","year":"2001","journal-title":"Autoimmunity"},{"issue":"1-2","key":"10.1016\/j.braindev.2021.02.003_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)01123-7","article-title":"Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome","volume":"745","author":"Chiba","year":"1997","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.braindev.2021.02.003_b0065","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0009922819898186","article-title":"Guillain-Barr\u00e9 Syndrome in a Teenage Girl: A Severe Case With Anti-GM2 Antibodies Associated With Acute CMV Infection and Literature Review","volume":"59","author":"Silva","year":"2020","journal-title":"Clin Pediatr (Phila)."},{"issue":"5","key":"10.1016\/j.braindev.2021.02.003_b0070","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4103\/neuroindia.NI_1226_15","article-title":"Antiganglioside antibodies profile in Guillain-Barr\u00e9 syndrome: correlation with clinical features, electrophysiological pattern, and outcome","volume":"65","author":"Naik","year":"2017","journal-title":"Neurol India."},{"key":"10.1016\/j.braindev.2021.02.003_b0075","series-title":"Red Book: 2018 Report of the Committee on Infectious Diseases","first-page":"310-7","article-title":"Cytomegalovirus Infection","author":"American Academy of Pediatrics","year":"2018"},{"issue":"1","key":"10.1016\/j.braindev.2021.02.003_b0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-510X(97)00174-3","article-title":"Acute cytomegalovirus infection and IgM anti-GM2 antibody","volume":"154","author":"Yuki","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.braindev.2021.02.003_b0085","doi-asserted-by":"crossref","first-page":"376e9","DOI":"10.1136\/jnnp.66.3.376","article-title":"Antiganglioside antibodies in Guillaine Barre syndrome after a recent cytomegalovirus infection","volume":"66","author":"Khalili-Shirazi","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.braindev.2021.02.003_b0090","first-page":"168","article-title":"CMV-associated axonal sensory-motor Guillain-Barr\u00e9 syndrome in a child: case report and review of the literature","volume":"20","author":"Spagnoli","year":"2016","journal-title":"Eur J PaediatrNeurol"},{"issue":"6","key":"10.1016\/j.braindev.2021.02.003_b0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.pediatrneurol.2011.01.021","article-title":"Acquired infantile abducens palsy associated with anti-GM2 antibodies","volume":"44","author":"Smyth","year":"2011","journal-title":"Pediatr Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760421000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760421000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:49:45Z","timestamp":1759952985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760421000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0387760421000280"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2021.02.003","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-GM2 antibody positive Guillain-Barr\u00e9 syndrome presenting with ataxia in a pediatric patient: An atypical manifestation","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}